{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-031930","form_type":"8-K","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2026-07-02T20:40:47+00:00","discovered_at":"2026-07-02T20:42:05.317458+00:00","generated_at":"2026-07-02T20:42:12.747444+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Ernexa Therapeutics posts updated investor presentation; no specific details provided","bullets":["Updated presentation posted on July 2, 2026, replacing the February 26, 2026 version.","Presentation available on company website from July 3, 2026.","No financial or operational updates disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-031930","json":"https://secwatch.observer/filing/0001493152-26-031930.json","markdown":"https://secwatch.observer/filing/0001493152-26-031930.md","text":"https://secwatch.observer/filing/0001493152-26-031930.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000149315226031930/0001493152-26-031930-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000149315226031930/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T20:42:12.747444+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}